Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000054

President and CEO sold 3,253 shares at $3.86 ($12,557)

  • President and CEO acquired 10,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-01 Exercise or conversion : show line 1 in the form +10,938 89,415 D
2020-06-02 Sale : show line 2 in the form −3,253 $3.86 $12,557 86,162 D
Open-market sales · 3,253 sh · avg $3.86 · $12,557

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-06-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,938 10,938 109,375 D
Loading xslF345X03/wf-form4_159121693539654.xml…